Myelography: current status and post-marketing experience with iotrolan K. Ringel OriginalPaper Pages: S14 - S17
Arthrography of the glenohumeral joint: experience with a non-ionic dimeric contrast agent and future perspectives L. KopkaM. FunkeE. Grabbe OriginalPaper Pages: S18 - S23
A Japanese phase III multicenter comparison of iotrolan 280 with iopamidol 300 in peripheral arteriography S. Hori OriginalPaper Pages: S24 - S29
Peripheral and penile angiography with iotrolan 280 versus non-ionic monomers: results of the European clinical phase II and III trials J. K. GmeinwieserB. -I. Wenzel-Hora OriginalPaper Pages: S30 - S38
Iotrolan in cerebral angiography: a Japanese phase III multicenter comparative study with iopamidol H. SumieH. Katayama OriginalPaper Pages: S39 - S44
Iotrolan, a non-ionic dimeric contrast agent in cerebral angiography S. Bien OriginalPaper Pages: S45 - S48
A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in head CT K. Sakurai OriginalPaper Pages: S49 - S53
Iotrolan in head and body CT — European experience O. SchubigerM. FriedrichW. Rodl OriginalPaper Pages: S54 - S57
A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in intravenous urography Y. NarimatsuK. Hiramatsu OriginalPaper Pages: S58 - S62
Iotrolan in urography: efficacy and tolerance in comparison with iohexol and iopamidol J. M. G. AdolphH. EngelkampB. I. Wenzel-Hora OriginalPaper Pages: S63 - S68
Renal tolerance of iotrolan 280 —a meta-analysis of 14 double-blind studies W. ClaußJ. DingerC. Meißner OriginalPaper Pages: S79 - S84
Clinical safety assessment of iotrolan 280 in European clinical studies O. M. Silvay-MandeauC. MeissnerB. I. Wenzel-Hora OriginalPaper Pages: S85 - S88
Intravascular iotrolan in the US: work in progress H. A. GoldsteinG. Jacob OriginalPaper Pages: S93 - S95
Future directions in vascular interventional radiology M. A. Bettmann OriginalPaper Pages: S99 - S102
The non-ionic dimers — some theoretical and clinical considerations P. Dawson OriginalPaper Pages: S103 - S106
Looking into the future: iotrolan and beyond H. P. NiendorfT. FritzschR. Schürmann OriginalPaper Pages: S107 - S111